Gentex GNTX Medical Products — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gentex in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Gentex’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gentex's medical products — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gentex's medical products — total revenue?
- Gentex (GNTX) reported medical products — total revenue of $353.62K in Q1 2026.
- How has Gentex's medical products — total revenue changed year-over-year?
- Gentex's medical products — total revenue decreased by 8.6% year-over-year, from $386.84K to $353.62K.
- What is the long-term trend for Gentex's medical products — total revenue?
- Over 2 years (2023 to 2025), Gentex's medical products — total revenue has grown at a 447.2% compound annual growth rate (CAGR), from $44.79K to $1.34M.
- What does medical products — total revenue mean?
- This metric represents the total gross revenue generated from the sale of medical-related products or services within the company's specialized healthcare segment. It tracks the financial contribution of non-automotive business lines, reflecting the company's efforts to diversify its technological applications beyond its core automotive mirror business. Monitoring this revenue stream helps investors assess the scale and growth trajectory of the company's secondary market initiatives.